These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 8045953

  • 1. The combined corticotropin-releasing hormone/lysine vasopressin test discloses a corticotroph phenotype.
    Bertagna X, Coste J, Raux-Demay MC, Letrait M, Strauch G.
    J Clin Endocrinol Metab; 1994 Aug; 79(2):390-4. PubMed ID: 8045953
    [Abstract] [Full Text] [Related]

  • 2. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J, Usui T, Tsukada T, Nakai Y, Koh T, Ishihara T, Tanaka I, Uchida K, Yoshimasa T, Nakano R.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [Abstract] [Full Text] [Related]

  • 3. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
    Bertagna X, Escourolle H, Pinquier JL, Coste J, Raux-Demay MC, Perles P, Silvestre L, Luton JP, Strauch G.
    J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
    [Abstract] [Full Text] [Related]

  • 4. Reliability of hormonal levels for assessing the hypothalamic-pituitary-adrenocortical system in clinical pharmacology.
    Coste J, Strauch G, Letrait M, Bertagna X.
    Br J Clin Pharmacol; 1994 Nov; 38(5):474-9. PubMed ID: 7893592
    [Abstract] [Full Text] [Related]

  • 5. Potentiation of the classic ovine corticotrophin releasing hormone stimulation test by the combined administration of small doses of lysine vasopressin.
    Favrod-Coune C, Raux-Demay MC, Proeschel MF, Bertagna X, Girard F, Luton JP.
    Clin Endocrinol (Oxf); 1993 Apr; 38(4):405-10. PubMed ID: 7686454
    [Abstract] [Full Text] [Related]

  • 6. Isolated adrenocorticotropic hormone deficiency secondary to hypothalamic deficit of corticotropin releasing hormone.
    Velardo A, Pantaleoni M, Zizzo G, Del Rio G, Coletta F, Carani C, Marrama P.
    J Endocrinol Invest; 1992 Jan; 15(1):53-7. PubMed ID: 1313844
    [Abstract] [Full Text] [Related]

  • 7. CRH and lysine-vasopressin stimulation tests in the diagnosis of hypoadrenalism secondary to hypothalamic or pituitary disorders.
    Cantalamessa L, Catania A, Baldini M, Orsatti A, Motta P, Peracchi G.
    Horm Metab Res; 1990 Jul; 22(7):389-93. PubMed ID: 2169450
    [Abstract] [Full Text] [Related]

  • 8. Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man.
    Lamberts SW, Verleun T, Oosterom R, de Jong F, Hackeng WH.
    J Clin Endocrinol Metab; 1984 Feb; 58(2):298-303. PubMed ID: 6319446
    [Abstract] [Full Text] [Related]

  • 9. Responsiveness of hypophyseal-adrenocortical axis to repetitive administration of synthetic ovine corticotropin-releasing hormone in patients with isolated adrenocorticotropin deficiency.
    Koide Y, Kimura S, Inoue S, Ikeda M, Uchida K, Ando J, Shimizu A, Oda K, Itakura M, Nabeshima I.
    J Clin Endocrinol Metab; 1986 Aug; 63(2):329-35. PubMed ID: 3013917
    [Abstract] [Full Text] [Related]

  • 10. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
    Reincke M, Allolio B, Würth G, Winkelmann W.
    J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
    [Abstract] [Full Text] [Related]

  • 11. Effects of repetitive administration of recombinant human interleukin-1 beta, an analog or corticotropin-releasing hormone combined with lysine vasopressin on rats with glucocorticoid-induced secondary adrenocortical insufficiency.
    Murakami N, Fukata J, Usui T, Naito Y, Tominaga T, Nakai Y, Masui Y, Nakao K, Imura H.
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1344-8. PubMed ID: 1312168
    [Abstract] [Full Text] [Related]

  • 12. Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia.
    Horiba N, Suda T, Aiba M, Naruse M, Nomura K, Imamura M, Demura H.
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2336-41. PubMed ID: 7629226
    [Abstract] [Full Text] [Related]

  • 13. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans.
    Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV.
    J Clin Endocrinol Metab; 1994 Jul; 79(1):140-4. PubMed ID: 8027217
    [Abstract] [Full Text] [Related]

  • 14. Responsiveness to corticotropin-releasing hormone and vasopressin in canine Cushing's syndrome.
    van Wijk PA, Rijnberk A, Croughs RJ, Wolfswinkel J, Selman PJ, Mol JA.
    Eur J Endocrinol; 1994 Apr; 130(4):410-6. PubMed ID: 8162173
    [Abstract] [Full Text] [Related]

  • 15. Human corticotropin-releasing factor plus lysine vasopressin test during glucocorticoid therapy.
    Hashimoto K, Suemaru S, Takao T, Sugawara M, Hattori T, Kageyama J, Takahashi K, Ota Z.
    J Clin Invest; 1988 Jul; 82(1):13-6. PubMed ID: 2839544
    [Abstract] [Full Text] [Related]

  • 16. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
    Gold PW, Kling MA, Khan I, Calabrese JR, Kalogeras K, Post RM, Avgerinos PC, Loriaux DL, Chrousos GP.
    Adv Biochem Psychopharmacol; 1987 Jul; 43():183-200. PubMed ID: 3035886
    [Abstract] [Full Text] [Related]

  • 17. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
    Hermus AR, Pieters GF, Pesman GJ, Smals AG, Benraad TJ, Kloppenborg PW.
    J Clin Endocrinol Metab; 1986 Apr; 62(4):634-9. PubMed ID: 3005353
    [Abstract] [Full Text] [Related]

  • 18. Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease.
    Dickstein G, DeBold CR, Gaitan D, DeCherney GS, Jackson RV, Sheldon WR, Nicholson WE, Orth DN.
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2934-41. PubMed ID: 8768855
    [Abstract] [Full Text] [Related]

  • 19. Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects.
    Rittmaster RS, Cutler GB, Sobel DO, Goldstein DS, Koppelman MC, Loriaux DL, Chrousos GP.
    J Clin Endocrinol Metab; 1985 May; 60(5):891-5. PubMed ID: 2984235
    [Abstract] [Full Text] [Related]

  • 20. Chronic stress and pituitary-adrenocortical responses to corticotropin-releasing hormone and vasopressin in female pigs.
    Janssens CJ, Helmond FA, Wiegant VM.
    Eur J Endocrinol; 1995 Apr; 132(4):479-86. PubMed ID: 7711887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.